+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

AIDS-defining diseases and HIV-related immunodeficiency in patients developing AIDS during the HAART era What is changing?



AIDS-defining diseases and HIV-related immunodeficiency in patients developing AIDS during the HAART era What is changing?



International Journal of Antimicrobial Agents 19(Suppl. 1): S9




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034333813

Download citation: RISBibTeXText


Related references

Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study. Sexually Transmitted Infections 76(2): 145-B-146, 2000

Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. Plos one 8(4): E59768, 2013

Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Journal of Infection and Public Health 8(1): 1-10, 2015

AIDS-defining opportunistic diseases in a cohort of 338 severely immunodepressed patients given HAART. AIDS 12(Suppl. 4): S82, 1998

Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. American Journal of Medicine 88(5b): 11s-15s, 1990

Supplement 2. Treatment Trends in Human Immunodeficiency Virus Disease || Stavudine in Patients with AIDS and AIDS-Related Complex: AIDS Clinical Trials Group 089. Journal of Infectious Diseases 171: S123-S130, 1995

AIDS Clinical Trials Group: phase I/II study of combination 2',3'-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex. American Journal of Medicine 88(5b): 27s-30s, 1990

Dietary intake in patients with acquired immunodeficiency syndrome aids patients with aids related complex and serologically positive human immunodeficiency virus patients correlations with nutritional status. Journal of Parenteral & Enteral Nutrition 14(6): 605-609, 1990

Dietary intake in patients with acquired immunodeficiency syndrome (Aids), patients with Aids-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status. Journal of Parenteral and Enteral Nutrition 14(6): 605-609, 1990

The distribution of overall AIDS-defining opportunistic infections and the concurrent level of immunodeficiency showed limited changes since the introduction of HAART. AIDS 14(Suppl. 4): S136, 2000

HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China. Aids Care 25(7): 915-925, 2013

Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Leukemia and Lymphoma 41(1-2): 105-116, 2001

Effects of the introduction of highly active antiretroviral therapy (HAART) on the temporal trend of diagnosis of AIDS and AIDS-defining disorders. Le Infezioni in Medicina 8(3): 134-138, 2000

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Journal of Infection 42(2): 134-139, 2001

Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009. HIV Medicine 14(8): 481-490, 2014